Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$242.49 - $301.46 $7.16 Million - $8.9 Million
29,522 Added 38340.26%
29,599 $7.27 Million
Q2 2022

Aug 05, 2022

BUY
$224.73 - $338.64 $449 - $677
2 Added 2.67%
77 $19,000
Q1 2022

May 12, 2022

BUY
$277.25 - $366.29 $20,793 - $27,471
75 New
75 $25,000
Q3 2021

Nov 09, 2021

SELL
$310.19 - $376.2 $1.23 Million - $1.49 Million
-3,950 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$262.71 - $351.17 $3.49 Million - $4.67 Million
-13,297 Reduced 77.1%
3,950 $1.23 Million
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $4.9 Million - $6.09 Million
17,151 Added 17865.63%
17,247 $5.5 Million
Q4 2020

Feb 16, 2021

SELL
$251.88 - $324.2 $31,736 - $40,849
-126 Reduced 56.76%
96 $31,000
Q3 2020

Nov 13, 2020

SELL
$255.22 - $317.0 $8,677 - $10,778
-34 Reduced 13.28%
222 $62,000
Q2 2020

Aug 13, 2020

SELL
$141.4 - $257.09 $16,261 - $29,565
-115 Reduced 31.0%
256 $62,000
Q1 2020

May 14, 2020

BUY
$130.51 - $196.01 $1,957 - $2,940
15 Added 4.21%
371 $54,000
Q4 2019

Feb 13, 2020

SELL
$159.31 - $223.54 $560,133 - $785,966
-3,516 Reduced 90.81%
356 $61,000
Q3 2019

Nov 13, 2019

BUY
$175.89 - $279.23 $464,525 - $737,446
2,641 Added 214.54%
3,872 $689,000
Q2 2019

Aug 13, 2019

SELL
$250.96 - $284.94 $11.9 Million - $13.5 Million
-47,467 Reduced 97.47%
1,231 $321,000
Q1 2019

May 14, 2019

SELL
$276.39 - $362.25 $4.22 Million - $5.53 Million
-15,278 Reduced 23.88%
48,698 $13.9 Million
Q4 2018

Feb 13, 2019

BUY
$281.08 - $444.25 $8.03 Million - $12.7 Million
28,555 Added 80.62%
63,976 $20.8 Million
Q3 2018

Nov 13, 2018

BUY
$354.53 - $449.75 $12.3 Million - $15.6 Million
34,613 Added 4283.79%
35,421 $15.9 Million
Q2 2018

Aug 09, 2018

BUY
$278.07 - $446.21 $224,680 - $360,537
808 New
808 $330,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.